CA2340120A1 - Transdermally delivered aspirin - Google Patents

Transdermally delivered aspirin Download PDF

Info

Publication number
CA2340120A1
CA2340120A1 CA002340120A CA2340120A CA2340120A1 CA 2340120 A1 CA2340120 A1 CA 2340120A1 CA 002340120 A CA002340120 A CA 002340120A CA 2340120 A CA2340120 A CA 2340120A CA 2340120 A1 CA2340120 A1 CA 2340120A1
Authority
CA
Canada
Prior art keywords
aspirin
solution
solvent
amine
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002340120A
Other languages
English (en)
French (fr)
Inventor
Alexander Galat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2340120A1 publication Critical patent/CA2340120A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002340120A 1999-06-10 1999-06-11 Transdermally delivered aspirin Abandoned CA2340120A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32934999A 1999-06-10 1999-06-10
US09/329,349 1999-06-10
PCT/US1999/012793 WO2000076315A1 (en) 1999-06-10 1999-06-11 Transdermally delivered aspirin

Publications (1)

Publication Number Publication Date
CA2340120A1 true CA2340120A1 (en) 2000-12-21

Family

ID=23284975

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002340120A Abandoned CA2340120A1 (en) 1999-06-10 1999-06-11 Transdermally delivered aspirin

Country Status (12)

Country Link
EP (1) EP1104236A1 (es)
JP (1) JP2003501447A (es)
KR (1) KR20010072412A (es)
AU (1) AU4552399A (es)
BR (1) BR9912954A (es)
CA (1) CA2340120A1 (es)
HU (1) HUP0103110A3 (es)
IL (1) IL141348A0 (es)
MX (1) MXPA01001490A (es)
TR (1) TR200100452T1 (es)
WO (1) WO2000076315A1 (es)
ZA (1) ZA200101153B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103528D0 (sv) 2001-10-21 2001-10-21 Jan Faergeman Topiska kompositioner med förstärkt effekt
WO2011076401A1 (de) 2009-12-23 2011-06-30 Holger Schankin Acetylsalicylsäure-haltige, im wesentlichen wasserfreie pharmazeutische zusammensetzungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725590A (en) * 1983-08-24 1988-02-16 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides

Also Published As

Publication number Publication date
KR20010072412A (ko) 2001-07-31
TR200100452T1 (tr) 2001-07-23
AU4552399A (en) 2001-01-02
WO2000076315A1 (en) 2000-12-21
EP1104236A1 (en) 2001-06-06
IL141348A0 (en) 2002-03-10
HUP0103110A3 (en) 2002-11-28
ZA200101153B (en) 2002-05-09
BR9912954A (pt) 2001-05-08
JP2003501447A (ja) 2003-01-14
MXPA01001490A (es) 2002-11-29
HUP0103110A2 (hu) 2002-05-29

Similar Documents

Publication Publication Date Title
JP6375037B2 (ja) 生薬等含有医薬組成物（肆）
KR0149494B1 (ko) 압출 가능한 탄성 경구용 제약학적 겔 조성물
US5563177A (en) Taste masking guaifenesin containing liquids
US4794117A (en) Process for solubilizing active ingredients and the thus-obtained pharmaceutical compositions
KR101458772B1 (ko) 페닐에프린을 함유하는 약제학적 현탁액 및 이의 제조 방법
IL160282A (en) Injection preparations for the control of the release of a pharmacologically active compound
HUT63539A (en) Bioactive compositions and process for forming bioactive coatings
JPH05509332A (ja) 薬剤運搬のための非水性ミクロエマルジョン
PT79656B (en) Process for preparing a non-aqueous ivermectin formulation with improved antiparasitic activity
JPH06104622B2 (ja) リポソ−ム製剤の製造法
PT1998762E (pt) Forma farmacêutica sólida contendo um agente activo de sabor mascarado
JPH0257049B2 (es)
US6007834A (en) Nasal melatonin composition
EP1848419B1 (en) Injectable preparations of diclofenac and its pharmaceutically acceptable salts
CA2001044C (en) Oral liquid pharmaceutical compositions of sulindac
KR890000907B1 (ko) 안정한 현탁액 제조용 고체 약물 제형의 제조방법
JPH0536416B2 (es)
EP0003682B1 (en) Process for solubilizing an insoluble drug and an aqueous solution prepared by this process
CA2340120A1 (en) Transdermally delivered aspirin
US5124152A (en) Parenteral formulation of metolazone
EP0867181A1 (en) Nasal melatonin composition
KR100567131B1 (ko) 쓴맛을 차폐한 아르기닌 함유 이부프로펜 경구투여 액상조성물
KR20000016365A (ko) 니메술리드를 함유하는 경구 투여용 약제학적 제제
US20050136116A1 (en) Stabilized prednisolone sodium phosphate solutions
JP2003081846A (ja) 液状鎮咳去痰薬

Legal Events

Date Code Title Description
FZDC Discontinued application reinstated
FZDE Discontinued